Logo Light ModeLogo Dark Mode
Why Subscribe?About UsAccreditationLearning Hub CentralLive EventsBlog

Learning Hub Central

Loading…

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure

Learning Hub Central

Filter by title, faculty, or specialty to find the course you're looking for.

SpecialtyHematology(36 courses)
All specialties

Hematology

36 courses

2026 NOSCM | Waldenstrom’s Macroglobulinemia

2026 NOSCM | Waldenstrom’s Macroglobulinemia

0.00 Credits
1 Chapter
Hematology
Free
2026 NOSCM | Selecting the Best Therapy for Relapsed Multiple Myeloma Patients after Transplant

2026 NOSCM | Selecting the Best Therapy for Relapsed Multiple Myeloma Patients after Transplant

0.00 Credits
1 Chapter
Hematology
Free
2026 NOSCM | Optimizing and Personalizing Treatment Selection UpFront in Multiple Myeloma Patients

2026 NOSCM | Optimizing and Personalizing Treatment Selection UpFront in Multiple Myeloma Patients

0.00 Credits
1 Chapter
Hematology
Free
2026 NOSCM | When ITP Becomes Steroid-Refractory: Treatment Selection

2026 NOSCM | When ITP Becomes Steroid-Refractory: Treatment Selection

0.00 Credits
1 Chapter
Hematology
Free
2026 NOSCM | How Do I Treat MDS and Secondary AML in 2026?

2026 NOSCM | How Do I Treat MDS and Secondary AML in 2026?

0.00 Credits
1 Chapter
Hematology
Free
2026 NOSCM | Acute Myeloid Leukemia

2026 NOSCM | Acute Myeloid Leukemia

0.00 Credits
1 Chapter
Hematology
Free
2026 NOSCM | Prognosis & Management of Large B-Cell Lymphomas Relapsing or Progressing after CAR T-cell Therapy: Is There Still Hope?

2026 NOSCM | Prognosis & Management of Large B-Cell Lymphomas Relapsing or Progressing after CAR T-cell Therapy: Is There Still Hope?

0.00 Credits
1 Chapter
Hematology
Free
2026 NOSCM | Optimizing Front-Line Therapy in CLL: What is Beyond BTKIs?

2026 NOSCM | Optimizing Front-Line Therapy in CLL: What is Beyond BTKIs?

0.00 Credits
1 Chapter
Hematology
Free
2026 NOSCM | Second Line and Beyond Therapeutic Options for Low-Grade NHL

2026 NOSCM | Second Line and Beyond Therapeutic Options for Low-Grade NHL

0.00 Credits
1 Chapter
Hematology
Free
2026 NOSCM | Optimizing Frontline Treatment for Follicular Lymphoma

2026 NOSCM | Optimizing Frontline Treatment for Follicular Lymphoma

0.00 Credits
1 Chapter
Hematology
Free
2026 NOSCM | Treatment Options for DLBCL in the Era of CAR-T Cell Therapy: How to Sequence?

2026 NOSCM | Treatment Options for DLBCL in the Era of CAR-T Cell Therapy: How to Sequence?

0.00 Credits
1 Chapter
Hematology
Free
2026 NOSCM | T-Cell NHL: Novel Treatment Paradigms

2026 NOSCM | T-Cell NHL: Novel Treatment Paradigms

0.00 Credits
1 Chapter
Hematology
Free
2026 NOSCM | Myelofibrosis: Diagnosis and Treatment

2026 NOSCM | Myelofibrosis: Diagnosis and Treatment

0.00 Credits
1 Chapter
Hematology
Free
2026 Updates in Cancer Therapies | Updates on B-Cell NHL

2026 Updates in Cancer Therapies | Updates on B-Cell NHL

0.00 Credits
1 Chapter
Hematology
Free
2026 Updates in Cancer Therapies | State-of-the-Art Treating De Novo Multiple Myeloma in 2026

2026 Updates in Cancer Therapies | State-of-the-Art Treating De Novo Multiple Myeloma in 2026

0.00 Credits
1 Chapter
Hematology
Free
2026 Updates in Cancer Therapies | Updates in CML and CLL

2026 Updates in Cancer Therapies | Updates in CML and CLL

0.00 Credits
1 Chapter
Hematology
Free
2025 Advances in Oncology | Update on Hemophilia Management

2025 Advances in Oncology | Update on Hemophilia Management

0.00 Credits
1 Chapter
Hematology
Free
2025 CCC | Lymphoma: State of the Art and Future Directions

2025 CCC | Lymphoma: State of the Art and Future Directions

0.00 Credits
1 Chapter
Hematology
Free
2025 CCC | Advances in the Treatment of Acute Leukemias and MDS

2025 CCC | Advances in the Treatment of Acute Leukemias and MDS

0.00 Credits
1 Chapter
Hematology
Free
2025 CCC | New Frontiers in Cellular Therapies for Cancer

2025 CCC | New Frontiers in Cellular Therapies for Cancer

0.00 Credits
1 Chapter
Hematology
Free
2025 CCC | Bispecifics in Hematologic Malignancies

2025 CCC | Bispecifics in Hematologic Malignancies

0.00 Credits
1 Chapter
Hematology
Free
2025 CCC | How to Get a CTEP LOI Approved

2025 CCC | How to Get a CTEP LOI Approved

0.00 Credits
1 Chapter
Hematology
Free
2025 NOSCM | Waldenstrom’s Macroglobulinemia

2025 NOSCM | Waldenstrom’s Macroglobulinemia

0.00 Credits
1 Chapter
Hematology
Free
2025 NOSCM | Clinical Challenges in the Management of Thrombosis and Acquired Inhibitors in Cancer Patients

2025 NOSCM | Clinical Challenges in the Management of Thrombosis and Acquired Inhibitors in Cancer Patients

0.00 Credits
1 Chapter
Hematology
Free
2025 NOSCM | Chimeric Antigen Receptor T-cell Therapy in B-cell lymphomas: Is Cure A Reality or Is It Still Just A Promise?

2025 NOSCM | Chimeric Antigen Receptor T-cell Therapy in B-cell lymphomas: Is Cure A Reality or Is It Still Just A Promise?

0.00 Credits
1 Chapter
Hematology
Free
Showing 25 of 36 courses

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure